Tue, Mar. 29, 11:16 AM
- Adamis Pharmaceuticals (ADMP +7.9%) enters into a definitive agreement to acquire privately held Conway, AR-based US Compounding, Inc. for 1.62M ADMP shares (~$9.7M) plus the assumption of certain debt. The deal should close in Q2.
- Founded in 2005, US Compounding makes customized medications for individual patients in more than 7,000 accounts.
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical products. Its products are concentrated in major therapeutic areas, respiratory disease, allergy, and oncology. The company combines specialty pharmaceuticals and... More
Industry: Drug Delivery & Accessories
Country: United States